Aldosterone in clinical nephrology--old hormone, new questions.
about
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentreSpironolactone is secure and reduces left ventricular hypertrophy in hemodialysis patients.Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease.
P2860
Aldosterone in clinical nephrology--old hormone, new questions.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Aldosterone in clinical nephrology--old hormone, new questions.
@en
Aldosterone in clinical nephrology--old hormone, new questions.
@nl
type
label
Aldosterone in clinical nephrology--old hormone, new questions.
@en
Aldosterone in clinical nephrology--old hormone, new questions.
@nl
prefLabel
Aldosterone in clinical nephrology--old hormone, new questions.
@en
Aldosterone in clinical nephrology--old hormone, new questions.
@nl
P356
P1476
Aldosterone in clinical nephrology--old hormone, new questions
@en
P2093
Anastasia Chrysostomou
Gavin J Becker
P304
P356
10.1093/NDT/GFP256
P407
P50
P577
2009-06-03T00:00:00Z